A Comparison of Screening Tools for the Early Detection of Peripheral Neuropathy in Adults with and without Type 2 Diabetes.

about

A Comparison of Screening Tools for the Early Detection of Peripheral Neuropathy in Adults with and without Type 2 Diabetes.

Item

http://www.wikidata.org/entity/Q47096990

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A Comparison of Screening Tool ...... h and without Type 2 Diabetes.

@en

A Comparison of Screening Tool ...... h and without Type 2 Diabetes.

@nl

type

Item

label

A Comparison of Screening Tool ...... h and without Type 2 Diabetes.

@en

A Comparison of Screening Tool ...... h and without Type 2 Diabetes.

@nl

prefLabel

A Comparison of Screening Tool ...... h and without Type 2 Diabetes.

@en

A Comparison of Screening Tool ...... h and without Type 2 Diabetes.

@nl

P1476

A Comparison of Screening Tool ...... th and without Type 2 Diabetes

@en

P2093

Kimberly G Baskette

http://www.w3.org/2001/XMLSchema#string

Shana L Pribesh

http://www.w3.org/2001/XMLSchema#string

Sheri R Colberg

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetic peripheral neuropathy and its evaluation in a clinical scenario: a review

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.

We can change the natural history of type 2 diabetes.

Performance of A1C for the classification and prediction of diabetes.

Foot screening technique in a diabetic population.

Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity: National Health and Nutrition Examination Survey 2001-2004.

The assessment of clinical distal symmetric polyneuropathy in type 1 diabetes: a comparison of methodologies from the Pittsburgh Epidemiology of Diabetes Complications Cohort.

Assessment of diabetic neuropathy using a point-of-care nerve conduction device shows significant associations with the LDIFLARE method and clinical neuropathy scoring

Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate.

The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy.

P304

1467213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/1467213

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Aaron Vinik

Jennifer J Brown

P577

2017-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29250555

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5698816

http://www.w3.org/2001/XMLSchema#string